Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | -4.72 | -1.50 | 13.71 |
| 6M | -0.08 | 0.82 | 58.21 |
| 1Y | 8.18 | 3.84 | 169.02 |
| 3Y | 0.00 | 10.06 | 239.94 |
HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹2,031 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 2.09. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| This FundBank of India Business Cycle Fund Growth | 0 | 464.98 CR | 2.43 |
| This FundWhiteOak Capital Pharma and Healthcare Fund Growth | 0 | 533.05 CR | 2.37 |
| This FundHDFC Pharma and Healthcare Fund Growth | 0 | 2030.81 CR | 2.09 |
| This FundICICI Prudential PSU Equity Fund Growth | 0 | 2021.84 CR | 2.08 |
| This FundNippon India Taiwan Equity Fund Growth | 3 | 519.5 CR | 2.42 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundBank of India Business Cycle Fund Growth | -1.9185 | 0 |
| This FundWhiteOak Capital Pharma and Healthcare Fund Growth | 6.5868 | 0 |
| This FundHDFC Pharma and Healthcare Fund Growth | 8.1784 | 0 |
| This FundICICI Prudential PSU Equity Fund Growth | 6.5641 | 100 |
| This FundNippon India Taiwan Equity Fund Growth | 165.3037 | 226.0626 |